344 related articles for article (PubMed ID: 11777970)
21. Regulation of MHC class II expression in human T-cell malignancies.
Holling TM; Schooten E; Langerak AW; van den Elsen PJ
Blood; 2004 Feb; 103(4):1438-44. PubMed ID: 14563641
[TBL] [Abstract][Full Text] [Related]
22. Suppression of human anti-porcine T-cell immune responses by major histocompatibility complex class II transactivator constructs lacking the amino terminal domain.
Yun S; Gustafsson K; Fabre JW
Transplantation; 1998 Jul; 66(1):103-11. PubMed ID: 9679829
[TBL] [Abstract][Full Text] [Related]
23. Notch1-mediated signaling induces MHC class II expression through activation of class II transactivator promoter III in mast cells.
Nakano N; Nishiyama C; Yagita H; Koyanagi A; Ogawa H; Okumura K
J Biol Chem; 2011 Apr; 286(14):12042-8. PubMed ID: 21321116
[TBL] [Abstract][Full Text] [Related]
24. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease.
Stüve O; Youssef S; Slavin AJ; King CL; Patarroyo JC; Hirschberg DL; Brickey WJ; Soos JM; Piskurich JF; Chapman HA; Zamvil SS
J Immunol; 2002 Dec; 169(12):6720-32. PubMed ID: 12471103
[TBL] [Abstract][Full Text] [Related]
25. [Major histocompatibility complex class II transactivator (CIITA) hammer- head ribozyme transfer inhibits major histocompatibility complex class II (MHC-II) expression in Jukart cells].
Guo R; Zou P; Song YP; Ma J; Lu HZ; Cao YL; Tong YJ
Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):925-8. PubMed ID: 14723817
[TBL] [Abstract][Full Text] [Related]
26. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells.
Nagarajan UM; Peijnenburg A; Gobin SJ; Boss JM; van den elsen PJ
J Immunol; 2000 Apr; 164(7):3666-74. PubMed ID: 10725724
[TBL] [Abstract][Full Text] [Related]
27. Cis-element dependence and occupancy of the human invariant chain promoter in CIITA-dependent and -independent transcription.
Tai AK; Zhou G; Chau K; Ono SJ
Mol Immunol; 1999 May; 36(7):447-60. PubMed ID: 10449097
[TBL] [Abstract][Full Text] [Related]
28. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.
Holtz R; Choi JC; Petroff MG; Piskurich JF; Murphy SP
Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124
[TBL] [Abstract][Full Text] [Related]
29. A novel element and a TEF-2-like element activate the major histocompatibility complex class II transactivator in B-lymphocytes.
Ghosh N; Piskurich JF; Wright G; Hassani K; Ting JP; Wright KL
J Biol Chem; 1999 Nov; 274(45):32342-50. PubMed ID: 10542275
[TBL] [Abstract][Full Text] [Related]
30. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression.
Chang CH; Guerder S; Hong SC; van Ewijk W; Flavell RA
Immunity; 1996 Feb; 4(2):167-78. PubMed ID: 8624807
[TBL] [Abstract][Full Text] [Related]
31. DNA alkylating agents alleviate silencing of class II transactivator gene expression in L1210 lymphoma cells.
Murphy SP; Holtz R; Lewandowski N; Tomasi TB; Fuji H
J Immunol; 2002 Sep; 169(6):3085-93. PubMed ID: 12218125
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1.
Lin JH; Lin JY; Chou YC; Chen MR; Yeh TH; Lin CW; Lin SJ; Tsai CH
Blood; 2015 Apr; 125(14):2228-38. PubMed ID: 25631773
[TBL] [Abstract][Full Text] [Related]
33. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
Murphy SP; Tomasi TB
Mol Reprod Dev; 1998 Sep; 51(1):1-12. PubMed ID: 9712312
[TBL] [Abstract][Full Text] [Related]
34. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
Goodwin BL; Xi H; Tejiram R; Eason DD; Ghosh N; Wright KL; Nagarajan U; Boss JM; Blanck G
Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807
[TBL] [Abstract][Full Text] [Related]
35. Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells.
Liu A; Takahashi M; Toba K; Zheng Z; Hashimoto S; Nikkuni K; Furukawa T; Koike T; Aizawa Y
Hematol Oncol; 1999 Dec; 17(4):149-60. PubMed ID: 10725870
[TBL] [Abstract][Full Text] [Related]
36. MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation.
Zhou X; Jiang Y; Lu L; Ding Q; Jiao Z; Zhou Y; Xin L; Chou KY
Immunology; 2007 Dec; 122(4):476-85. PubMed ID: 17645498
[TBL] [Abstract][Full Text] [Related]
37. Highly efficient peptide binding and T cell activation by MHC class II molecules of CIITA-transfected cells.
Martinez-Soria E; Siegrist CA; Mach B
Int Immunol; 1996 Apr; 8(4):543-9. PubMed ID: 8671641
[TBL] [Abstract][Full Text] [Related]
38. CIITA enhances HIV-1 attachment to CD4+ T cells leading to enhanced infection and cell depletion.
Porter KA; Kelley LN; Nekorchuk MD; Jones JH; Hahn AB; de Noronha CM; Harton JA; Duus KM
J Immunol; 2010 Dec; 185(11):6480-8. PubMed ID: 21041720
[TBL] [Abstract][Full Text] [Related]
39. The Smad3 protein is involved in TGF-beta inhibition of class II transactivator and class II MHC expression.
Dong Y; Tang L; Letterio JJ; Benveniste EN
J Immunol; 2001 Jul; 167(1):311-9. PubMed ID: 11418665
[TBL] [Abstract][Full Text] [Related]
40. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
Masternak K; Reith W
EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
